Changes in ctDNA can predict long-term outcomes in certain patients with metastatic CRC on immune checkpoint inhibitors.

Using ctDNA test results to guide adjuvant treatment with pembrolizumab can provide benefits in patients with dMMR solid tumors, data suggest.

MOMA Therapeutics, a clinical-stage biopharmaceutical company discovering and developing a new generation of precision therapeutics, today announced that the first patient has been dosed in its Phase ...

GSK’s Jemperli has been cleared for routine use by the NHS as a first-line treatment for hundreds of women with dMMR/MSI-H endometrial cancer.

The Lynparza/Imfinzi regimen reduced that endpoint for patients with pMMR disease by 43% compared to the control arm, while Imfinzi cut it by 57% for the dMMR subjects.

Invikafusp alfa, a dual T-cell agonist targeting subsets of tumor-infiltrating lymphocytes, can elicit responses in patients with heavily pretreated gastrointestinal cancers, according to research ...

Undergoing sentinel lymph node biopsy and radical hysterectomy without pelvic lymphadenectomy may reduce the risk of retroperitoneal nodal recurrence and cancer-specific death.

Immunosurveillance articles from across Nature Portfolio Atom RSS Feed Immunosurveillance is a term used to describe the processes by which cells of the immune system look for and recognise ...